Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cavit vs IRM in Ferric Sulfate Pulpotomy
NCT05557812Phase 1Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Feb 2023
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 1, randomised trial in pulpitis (2 arms), sponsored by Virginia Commonwealth University. Primary endpoints: Clinical success rate at 36 months and Radiographic success rate at 36 months. Started Feb 2023; status: completed.
02
Conditions
pulpitis
Beyond the preview
Go deeper on NCT05557812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05557812.